Continuity Health & Safety

Supply crunch deepens for vital allergy drug Epipen

The ​UK’s Epipen shortage has deepened after US drug giant Mylan began rationing access to the vital medicine.
In an update published last week, Mylan said manufacturing problems were now restricting the supply of its Epipen Junior product containing 0.15mg of adrenalin. Previously, shortages had only impacted the 0.3mg version for adults.

Epipens work by reversing the life-threatening symptoms of severe anaphylaxis – caused by shellfish, bee or nut allergies – which if left untreated can progress rapidly and be fatal if a person’s heart or breathing stops.

> Read entire article Supply crunch deepens for vital allergy drug Epipen | Iain Withers | The Guardian

Leave a comment

%d bloggers like this: